No black box warning on record for Gavreto

As of the latest FDA labeling reviewed, Gavreto (PRALSETINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gavreto medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Infections, Including Opportunistic Infections: Monitor for signs and symptoms of infection and treat appropriately. Withhold, reduce the dose, or permanently discontinue GAVRETO based on severity. ( 2.3 , 5.1 ) Interstitial Lung Disease (ILD)/Pneumonitis: Withhold GAVRETO for Grade 1 or 2 reactions until resolution and then resume at a reduced dose. Permanently

No black box warning on record for Gavreto

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Infections, Including Opportunistic Infections: Monitor for signs and symptoms of infection and treat appropriately. Withhold, reduce the dose, or permanently discontinue GAVRETO based on severity. ( 2.3 , 5.1 ) Interstitial Lung Disease (ILD)/Pneumonitis: Withhold GAVRETO for Grade 1 or 2 reactions until resolution and then resume at a reduced dose. Permanently

Gavreto Black Box Warning

No black box warning on record for Gavreto

Other warnings & precautions

Gavreto Black Box Warning

No black box warning on record for Gavreto

Other warnings & precautions